Navigation Links
UBC professor wins Canada's top pharmaceutical research award
Date:11/19/2012

UBC microbiologist Robert E.W. Hancock has received the Prix Galien 2012 Research Award, widely considered the most prestigious honour in Canadian pharmaceutical research and innovation. Hancock is being recognized for pioneering work unravelling the complex interactions between antibiotics and bacteria.

"The Prix Galien is a testament to Bob Hancock's profound impact on Canadian health research," said Simon Peacock, Dean of UBC's Faculty of Science. "His research focuses on the growing challenge of antibiotic resistance and has resulted in new therapeutic approaches to infectious diseases, like malaria."

Hancock is a leader in Canadian health research, focusing on the prevention and treatment of infectious disease. At UBC he established the Centre for Microbial Diseases and Immunity Research (CMDR) and also co-founded the Centre for Drug Research and Development (CDRD), a national not-for-profit drug development and commercialization centre.

Hancock's research interests include antibiotic uptake and resistance, cationic peptides as novel antimicrobials, innate immunity, and bacterial genomics. His breakthrough discovery of a novel way of selectively modulating immunity and suppressing harmful inflammation while retaining protective immunity has, according to Prix Galien Canada, the potential to revolutionize human healthcare.


'/>"/>

Contact: Silvia Moreno-Garcia
silvia.moreno-garcia@science.ubc.ca
604-822-5001
University of British Columbia
Source:Eurekalert

0

GOOD

Page: 1

Related medicine news :

1. Guys, take note: Male birth control pill may be ready soon, says Texas A&M professor
2. IHME professor named first health measurement winner of prestigious innovation award
3. From textbook to flexbook: Professor uses new collaborative tool in the classroom
4. President Obama names SF State math professor a top young scientist
5. Women professorships low in some Scandinavian universities due to sexism
6. Louisiana Tech biomedical engineering professor earns recognition, funding for research
7. Clemson professor awarded nearly $600,000 4-year grant to study language of plants
8. Louisiana Tech University professor earns NSF Early Career Development grant
9. Edison Pharmaceuticals announces initiation of EPI-743 Phase 2B Leigh Syndrome Clinical Trial
10. Environmentally friendly chemistry important for manufacturing pharmaceuticals
11. Taiho Pharmaceutical unveils data on 8 novel anticancer compounds
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/19/2013)... 19, 2013 The deadline to ... this Friday, June 21 at midnight ET. This ... and innovative people who’ve raised the bar on ... http://www.minonline.com/ima . , Any consumer and b2b ... is eligible to enter. Additionally, advertising agencies and ...
(Date:6/19/2013)... Chrysler made news recently when it refused to accept the ... Jeep models in question are the 1993-2004 Jeep Grand Cherokee ... are vulnerable to fire and explosion in a crash. (1) ... have been alleged to catch fire or explode upon impact. ... rear-end crashes, which resulted in 44 deaths and the Liberty ...
(Date:6/19/2013)... New York (PRWEB) June 19, 2013 ... and pancreatic cancer continue to mount in courts throughout ... Food & Drug Administration (FDA) recently held a meeting ... drugs known as incretin mimetics. According to a ... additional data from the makers of Januvia and similar ...
(Date:6/19/2013)... - In a major international study led by researchers ... the targeted therapy ibrutinib continues to show remarkable promise ... lymphoma (MCL). , The most recent interim findings of ... the New England Journal of Medicine . Previous ... 54th American Society of Hematology Annual Meeting and Exposition. ...
(Date:6/19/2013)... A new understanding of the genetic process that can ... potentially dangerous lesions for some women, and also raises ... in certain cases suggesting they could actually trigger ... analysis provides a clearer picture of the chromosomal and ... sometimes leads to chronic infection and, in less than ...
Breaking Medicine News(10 mins):Health News:Entry Deadline for min’s Integrated Marketing Awards Is This Friday, June 21 2Health News:Zinda & Davis PLLC: Why the Chrysler Recall Refusal Matters And May Set a Dangerous Precedent 2Health News:Zinda & Davis PLLC: Why the Chrysler Recall Refusal Matters And May Set a Dangerous Precedent 3Health News:Januvia Lawsuit News: Bernstein Liebhard LLP Comments on Recent FDA Meeting to Discuss Safety of Januvia and Other Incretin Mimetics 2Health News:Januvia Lawsuit News: Bernstein Liebhard LLP Comments on Recent FDA Meeting to Discuss Safety of Januvia and Other Incretin Mimetics 3Health News:Ibrutinib continues strong showing against mantle cell lymphoma 2Health News:Genetics of cervical cancer raise concern about antiviral therapy in some cases 2
... Drug,Discovery invites you to submit your poster presentation and ... CDD Community Meeting,(a free, 1-day event) on October 7th. ... CDD community and all scientists to get together, discuss,their ... the,community., Early List of Confirmed Speakers: ...
... surgery can be particularly difficult and confusing for older ... issue of the Journal of Bone and Joint ... University School of Medicine, and colleagues report that older ... exploring surgical treatment options. , The researchers audiotaped ...
... Plan to Employers, DALLAS, July 31 ... leader in disease prevention,and Physicians Planning Group ... alliance that will give PPG employee benefit ... groundbreaking prevention program to,employers. Physicians Planning Group ...
... DYNT ) today announced the election of Mark ... the vacancy created by the,recent passing of long-time board ... a principal of NightWatch Capital, a mid-sized,value-oriented hedge fund. ... Earnings, an operations improvement consulting firm for banks and,corporations. ...
... REY, Calif., July 31 Martin Schiff, M.D. has,been a ... century, as shown in "Who,s Who in America," "Who,s Who ... "Diets and pills and junk don,t work," Schiff contends. ... more than fifty-thousand,hours, and I know that your weight is ...
... 2008 The editors of The Journal of Allergy ... issue, highlighting AIDS and AIDS research. The Journal of ... official journal of the American Academy of Allergy and Clinical ... with the XVII International AIDS Conference, taking place at Centro ...
Cached Medicine News:Health News:Collaborative Drug Discovery 2nd Annual Community Meeting - Oct. 7, 2008, Speakers Confirmed & Call for Posters 2Health News:Communication gap exists between seniors and surgeons, study finds 2Health News:U.S. Preventive Medicine(R) Forms Strategic Alliance with Physicians Planning Group 2Health News:U.S. Preventive Medicine(R) Forms Strategic Alliance with Physicians Planning Group 3Health News:Dynatronics Elects Mark A. Crockett to its Board of Directors 2Health News:'Who's Who' Weight Specialist Martin Schiff, M.D., 86, Devoting Rest of Life to Spreading Truth About Diets, Won't Accept Compensation From Anyone, Sending Complete Guide Free to All 2Health News:The Journal of Allergy and Clinical Immunology devotes special issue to AIDS 2
(Date:6/19/2013)... -- Ellen MacArthur Foundation meddelade i ... kommer att vara en partner för att hjälpa ... Efter stiftelsens framgångsrika partnerskap med Renault, BT/Cisco ... att ansluta sig som partner för att få ... verksamhet och stödja stiftelsens arbete inom utbildning. ...
(Date:6/19/2013)... , June 19, 2013 The Physician-Patient Alliance ... alarm fatigue. The need to urgently address this ... its Sentinel Event Alert #50 , "Medical device alarm safety ... database, between January 2008 and June 2012, there were 98 ... resulted in death (82%) , 13 resulted in permanent ...
(Date:6/19/2013)...   BioCision , a leader in advanced ... many areas of medical and scientific research, announced ... U.S. Patent Office that apply to two of ... handling to ensure the consistency of test conditions ... Patent number 8,388,912 covers CoolSink® ...
Breaking Medicine Technology:Ellen MacArthur Foundation presenterar Philips som global partner vid det konstituerande internationella toppmötet om cirkulär ekonomi 2Ellen MacArthur Foundation presenterar Philips som global partner vid det konstituerande internationella toppmötet om cirkulär ekonomi 3Three Lessons Learned to Reduce Alarm Fatigue and Improve Alarm Management and Patient Safety in Hospitals 2Three Lessons Learned to Reduce Alarm Fatigue and Improve Alarm Management and Patient Safety in Hospitals 3BioCision Announces Two New U.S. Patents for Thermo-Conductive Products that Standardize Sample Handling in Laboratory Research 2
... Inc. (Nasdaq: KERX ) today announced that ... from previous clinical trials of Zerenex™ (ferric citrate) were ... the American Society of Nephrology (ASN) Kidney Week 2011 ... ferric iron-based drug candidate, is currently in Phase 3 ...
... and WASHINGTON, Nov. 14, 2011 Nektar Therapeutics (NASDAQ: ... data for NKTR-192, a novel mu-opioid agonist, was presented ... Neuroscience being held November 12-16, 2011 in Washington, DC. ... for the treatment of acute pain.  It is designed ...
Cached Medicine Technology:Keryx Biopharmaceuticals Announces Highlights from Zerenex™ (ferric citrate) Poster Presentations at American Society of Nephrology Kidney Week 2011 Annual Meeting 2Keryx Biopharmaceuticals Announces Highlights from Zerenex™ (ferric citrate) Poster Presentations at American Society of Nephrology Kidney Week 2011 Annual Meeting 3Keryx Biopharmaceuticals Announces Highlights from Zerenex™ (ferric citrate) Poster Presentations at American Society of Nephrology Kidney Week 2011 Annual Meeting 4Positive Data for Nektar's New Mu-Opioid Analgesic Molecule to Treat Acute Pain Highlighted at Neuroscience 2011 2Positive Data for Nektar's New Mu-Opioid Analgesic Molecule to Treat Acute Pain Highlighted at Neuroscience 2011 3Positive Data for Nektar's New Mu-Opioid Analgesic Molecule to Treat Acute Pain Highlighted at Neuroscience 2011 4Positive Data for Nektar's New Mu-Opioid Analgesic Molecule to Treat Acute Pain Highlighted at Neuroscience 2011 5Positive Data for Nektar's New Mu-Opioid Analgesic Molecule to Treat Acute Pain Highlighted at Neuroscience 2011 6
... Care Manager is an electronic ... and data management of wounds ... was developed using industry expert ... with the most current assessment ...
... 3000 is a computerized medical ... 3000 encompasses a wide array ... criteria sets and decision tree ... clinicians, medical educators, nurses and ...
... is the handheld version ... a drug interaction analyzer ... and generic drugs. iFacts™ ... refer to accurate and ...
... for 2005, this practical handbook is ... of cancer chemotherapy. The book provides ... of over 100 drugs both on ... cancer treatment. This new edition includes ...
Medicine Products: